Skip to main content
. 2024 Sep 23;15:1451748. doi: 10.3389/fgene.2024.1451748

TABLE 2.

Percentages of participants with unsatisfactory results in the period 2019–2023.

HLA typing (%) Crossmatching (%) HLA-specific antibody detection (%) HLA-specific antibody identification CDC (%) HLA-specific antibody identification SPA SA (%)
% Participants with unsatisfactory results 3.2 1.2 2.4 9.0 0.3